Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate Efficacy of CMS008618 for Common Cold

NACompletedINTERVENTIONAL
Enrollment

701

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

June 26, 2019

Study Completion Date

June 26, 2019

Conditions
Common Cold
Interventions
DEVICE

ColdZyme

"ColdZyme® Mouth Spray, a CE -marked device with the following composition of the spray solution: glycerol, purified water, cod trypsin, ethanol (\<1 %), calcium chloride, trometamol and menthol.~ColdZyme is a non-sterile mouth spray packaged in a primary container consisting of a 20 ml semi-transparent plastic bottle, pump, actuator (spray nozzle) and an actuator terminal cap."

DEVICE

ColdZyme Placebo

The placebo mouth spray solution has the following composition: ethanol (\<1 %), menthol and water. The placebo mouth spray is packaged in a primary container consisting of a 20 ml semitransparent plastic bottle, pump, actuator (spray nozzle) and an actuator terminal cap.

Trial Locations (10)

Unknown

analyze & realize GmbH, Berlin

emovis GmbH, Berlin

Klinische Forschung Berlin-Mitte GmbH, Berlin

Klinische Forschung Berlin, Berlin

Polikum Institut GmbH, Berlin

Praxis Frau Barbara Grube, Berlin

Thomas Wünsche, Berlin

BioTeSys GmbH, Esslingen am Neckar

Praxis Dr. med. Gudrun Ruhland, Koßdorf

SIBAmed Studienzentrum GmbH und Co. KG, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Analyze & Realize

NETWORK

lead

Enzymatica AB

INDUSTRY